Anthony Petrone
Stock Analyst at Mizuho Securities
(4.30)
# 1,310
Out of 4,455 analysts
628
Total ratings
49.7%
Success rate
6.6%
Average return
Main Sectors:
Stocks Rated by Anthony Petrone
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| HAE Haemonetics | Maintained: Buy | $70 → $85 | $77.29 | +9.98% | 69 | Jun 15, 2026 | |
| DXCM DexCom | Maintained: Buy | $75 → $85 | $70.14 | +21.19% | 11 | Jun 8, 2026 | |
| COO The Cooper Companies | Maintained: Buy | $100 → $85 | $71.02 | +19.68% | 39 | Jun 3, 2026 | |
| MDT Medtronic | Maintained: Buy | $120 → $100 | $80.98 | +23.49% | 28 | Jun 3, 2026 | |
| MMED MiniMed Group | Maintained: Buy | $21 | $14.24 | +47.47% | 3 | Jun 3, 2026 | |
| LNTH Lantheus Holdings | Maintained: Buy | $100 → $115 | $109.80 | +4.74% | 35 | May 27, 2026 | |
| STAA STAAR Surgical Company | Maintained: Hold | $22 → $27 | $29.29 | -7.82% | 31 | May 14, 2026 | |
| TFX Teleflex | Maintained: Hold | $135 → $140 | $129.86 | +7.81% | 21 | May 8, 2026 | |
| TNDM Tandem Diabetes Care | Maintained: Hold | $22 → $24 | $16.24 | +47.78% | 7 | May 8, 2026 | |
| MNKD MannKind | Maintained: Buy | $8 → $7 | $4.14 | +69.08% | 4 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $24 → $20 | $8.75 | +128.57% | 33 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $85 → $90 | $83.43 | +7.87% | 27 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | CHF 77.10 → CHF 68.99 | $55.20 | +24.97% | 23 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $12 → $5 | $3.49 | +43.27% | 7 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $70 → $55 | $45.72 | +20.30% | 19 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $255 → $235 | $200.29 | +17.33% | 30 | May 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $10 → $8 | $3.93 | +103.56% | 20 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $130 → $160 | $144.42 | +10.79% | 26 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $90 → $80 | $65.76 | +21.65% | 20 | Apr 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $40 → $55 | $44.93 | +22.41% | 3 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $95 → $100 | $90.78 | +10.16% | 29 | Apr 24, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $44.23 | - | 23 | Apr 21, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $125 → $115 | $94.12 | +22.18% | 20 | Apr 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $525 | $404.70 | +29.73% | 17 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $20 | $5.72 | +249.65% | 5 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $30 | $28.45 | +5.45% | 5 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $88.38 | +13.15% | 30 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $100 | $56.14 | +78.13% | 1 | Apr 13, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $65 | $149.22 | n/a | 1 | Jun 13, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $175 | $93.10 | n/a | 2 | Nov 5, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $70 | $95.66 | n/a | 1 | Sep 16, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $20 | $0.7056 | n/a | 3 | Aug 11, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $45 | $62.92 | n/a | 7 | Aug 10, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Buy | $86 | $18.76 | n/a | 1 | May 20, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $15 | $0.362 | n/a | 1 | Sep 17, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | $25 → $18 | $10.29 | n/a | 8 | Aug 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $7 | $0.0001 | n/a | 5 | Dec 3, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $7 → $6 | $0.2646 | n/a | 7 | Aug 17, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $80 → $95 | - | n/a | 4 | Mar 5, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | $93 | $218.29 | n/a | 1 | Aug 25, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $97 | $9.95 | n/a | 1 | Aug 2, 2016 |
Haemonetics
Jun 15, 2026
Maintained: Buy
Price Target: $70 → $85
Current: $77.29
Upside: +9.98%
DexCom
Jun 8, 2026
Maintained: Buy
Price Target: $75 → $85
Current: $70.14
Upside: +21.19%
The Cooper Companies
Jun 3, 2026
Maintained: Buy
Price Target: $100 → $85
Current: $71.02
Upside: +19.68%
Medtronic
Jun 3, 2026
Maintained: Buy
Price Target: $120 → $100
Current: $80.98
Upside: +23.49%
MiniMed Group
Jun 3, 2026
Maintained: Buy
Price Target: $21
Current: $14.24
Upside: +47.47%
Lantheus Holdings
May 27, 2026
Maintained: Buy
Price Target: $100 → $115
Current: $109.80
Upside: +4.74%
STAAR Surgical Company
May 14, 2026
Maintained: Hold
Price Target: $22 → $27
Current: $29.29
Upside: -7.82%
Teleflex
May 8, 2026
Maintained: Hold
Price Target: $135 → $140
Current: $129.86
Upside: +7.81%
Tandem Diabetes Care
May 8, 2026
Maintained: Hold
Price Target: $22 → $24
Current: $16.24
Upside: +47.78%
MannKind
May 7, 2026
Maintained: Buy
Price Target: $8 → $7
Current: $4.14
Upside: +69.08%
May 7, 2026
Maintained: Buy
Price Target: $24 → $20
Current: $8.75
Upside: +128.57%
May 7, 2026
Maintained: Buy
Price Target: $85 → $90
Current: $83.43
Upside: +7.87%
May 7, 2026
Maintained: Buy
Price Target: CHF 77.10 → CHF 68.99
Current: $55.20
Upside: +24.97%
May 6, 2026
Maintained: Hold
Price Target: $12 → $5
Current: $3.49
Upside: +43.27%
May 5, 2026
Maintained: Buy
Price Target: $70 → $55
Current: $45.72
Upside: +20.30%
May 4, 2026
Maintained: Buy
Price Target: $255 → $235
Current: $200.29
Upside: +17.33%
Apr 30, 2026
Maintained: Buy
Price Target: $10 → $8
Current: $3.93
Upside: +103.56%
Apr 30, 2026
Maintained: Buy
Price Target: $130 → $160
Current: $144.42
Upside: +10.79%
Apr 30, 2026
Maintained: Buy
Price Target: $90 → $80
Current: $65.76
Upside: +21.65%
Apr 29, 2026
Maintained: Buy
Price Target: $40 → $55
Current: $44.93
Upside: +22.41%
Apr 24, 2026
Maintained: Buy
Price Target: $95 → $100
Current: $90.78
Upside: +10.16%
Apr 21, 2026
Maintained: Buy
Price Target: n/a
Current: $44.23
Upside: -
Apr 20, 2026
Maintained: Hold
Price Target: $125 → $115
Current: $94.12
Upside: +22.18%
Apr 13, 2026
Rated: Hold
Price Target: $525
Current: $404.70
Upside: +29.73%
Apr 13, 2026
Maintained: Buy
Price Target: $20
Current: $5.72
Upside: +249.65%
Apr 13, 2026
Maintained: Buy
Price Target: $30
Current: $28.45
Upside: +5.45%
Apr 13, 2026
Maintained: Buy
Price Target: $100
Current: $88.38
Upside: +13.15%
Apr 13, 2026
Maintained: Buy
Price Target: $100
Current: $56.14
Upside: +78.13%
Jun 13, 2025
Maintained: Buy
Price Target: $65
Current: $149.22
Upside: n/a
Nov 5, 2021
Maintained: Buy
Price Target: $175
Current: $93.10
Upside: n/a
Sep 16, 2021
Rated: Buy
Price Target: $70
Current: $95.66
Upside: n/a
Aug 11, 2021
Rated: Buy
Price Target: $20
Current: $0.7056
Upside: n/a
Aug 10, 2021
Rated: Buy
Price Target: $45
Current: $62.92
Upside: n/a
May 20, 2021
Rated: Buy
Price Target: $86
Current: $18.76
Upside: n/a
Sep 17, 2020
Initiated Coverage: Buy
Price Target: $15
Current: $0.362
Upside: n/a
Aug 13, 2020
Maintained: Hold
Price Target: $25 → $18
Current: $10.29
Upside: n/a
Dec 3, 2019
Maintained: Buy
Price Target: $7
Current: $0.0001
Upside: n/a
Aug 17, 2018
Reiterated: Buy
Price Target: $7 → $6
Current: $0.2646
Upside: n/a
Mar 5, 2018
Reiterated: Hold
Price Target: $80 → $95
Current: -
Upside: n/a
Aug 25, 2017
Maintained: Buy
Price Target: $93
Current: $218.29
Upside: n/a
Aug 2, 2016
Reiterated: Hold
Price Target: $97
Current: $9.95
Upside: n/a